financetom
Business
financetom
/
Business
/
Palo Alto Networks Poised for Solid Q4, CyberArk Deal an Offensive Move, Truist Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palo Alto Networks Poised for Solid Q4, CyberArk Deal an Offensive Move, Truist Says
Aug 18, 2025 12:25 PM

03:05 PM EDT, 08/18/2025 (MT Newswires) -- Palo Alto Networks ( PANW ) is expected to report fiscal Q4 results in line with expectations, backed by a solid finish in July, Truist Securities said in a note Monday.

The company reaffirmed guidance when it announced a $25 billion agreement to acquire CyberArk (CYBR) late last month. Truist called the acquisition an offensive move that expands Palo Alto's reach into identity security, a market seen as ready for consolidation, and noted significant cross-sell opportunities within the company's installed base.

The deal could help make Palo Alto Networks ( PANW ) the most comprehensive cybersecurity platform and a leader in securing emerging agentic AI systems, according to the note.

For fiscal 2026, the company expects revenue of $10.38 billion, up 13% year over year, broadly in line with consensus expectations. Analysts surveyed by FactSet expect $10.42 billion.

Palo Alto Networks ( PANW ) is expected to report fiscal Q4 results on Aug. 18, after the market close.

Truist said the company is strongly positioned with the industry's most comprehensive cybersecurity platform, set to benefit from vendor consolidation and accelerating AI adoption.

The firm maintained a buy rating with a $205 price target, implying 18% upside.

Price: 176.15, Change: -0.94, Percent Change: -0.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LaGuardia Airport Closed After Air Canada Express CRJ900 Collides With Firefighting Vehicle, Killing Two Pilots and Canceling 500 Flights
LaGuardia Airport Closed After Air Canada Express CRJ900 Collides With Firefighting Vehicle, Killing Two Pilots and Canceling 500 Flights
Mar 23, 2026
08:37 AM EDT, 03/23/2026 (MT Newswires) -- LaGuardia Airport was closed early Monday after an Air Canada Express regional jet struck an airport firefighting vehicle on the runway late Sunday, killing two pilots and injuring dozens, the Federal Aviation Administration said. The Bombardier CRJ900, operated by Jazz Aviation as Flight AC8646 from Montreal, collided with the vehicle around 11:40 p.m....
Enlivex Gets Investigational New Drug Clearance in US for Phase 2b Trial of Knee Osteoarthritis Treatment
Enlivex Gets Investigational New Drug Clearance in US for Phase 2b Trial of Knee Osteoarthritis Treatment
Mar 23, 2026
08:34 AM EDT, 03/23/2026 (MT Newswires) -- Enlivex ( ENLV ) said Monday it obtained investigational new drug clearance from the US Food and Drug Administration to begin a phase 2b trial of Allocetra, a potential treatment for moderate-to-severe age-related symptomatic primary knee osteoarthritis. The phase 2b trial will evaluate the efficacy and safety of intra-articular injections of the treatment,...
Newark airport's control tower evacuated after burning smell, FAA says
Newark airport's control tower evacuated after burning smell, FAA says
Mar 23, 2026
WASHINGTON, March 23 (Reuters) - The control tower at Newark airport outside New York City was temporarily evacuated and officials ordered a ground stop on Monday morning after a burning smell, the FAA said. Arrivals and departures are temporarily paused at Newark Liberty International Airport in New Jersey after air traffic controllers evacuated the tower because of a burning smell...
Lexicon Pharmaceuticals, Novo Nordisk Report Initiation of Phase 1 Study of Potential Obesity Treatment
Lexicon Pharmaceuticals, Novo Nordisk Report Initiation of Phase 1 Study of Potential Obesity Treatment
Mar 23, 2026
08:38 AM EDT, 03/23/2026 (MT Newswires) -- Lexicon Pharmaceuticals ( LXRX ) and Novo Nordisk ( NVO ) said Monday that Novo Nordisk ( NVO ) has initiated a phase 1 study with LX9851 as a treatment for obesity and associated metabolic disorders. The companies said Lexicon earned a second $10 million milestone payment in 2026 from Novo Nordisk (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved